Empire Life Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-274,108
Closed -$29M 108
2018
Q1
$29M Sell
274,108
-161,750
-37% -$18.8M 2.06% 11
2017
Q4
$51.1M Buy
435,858
+37,051
+9% +$4.19M 3.94% 3
2017
Q3
$45.3M Sell
398,807
-25,684
-6% -$2.96M 3.66% 3
2017
Q2
$52.9M Buy
424,491
+4,188
+1% +$497K 4.61% 2
2017
Q1
$42.2M Sell
420,303
-24,467
-6% -$2.77M 4.12% 2
2016
Q4
$44.6M Buy
+444,770
New +$47.7M 3.61% 3

Other funds holding ZBH

Empire Life Investments's ZBH Position: Q2 2018 in Review

Empire Life Investments sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 274,108 shares — an estimated $29M sold.

Empire Life Investments first reported a position in ZBH in Q4 2016 and held it in 6 quarters. The position peaked at $52.9M in Q2 2017. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Empire Life Investments reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
  • Empire Life Investments sold 274,108 Zimmer Biomet shares in Q2 2018, an estimated $29M.
  • Empire Life Investments first reported a position in Zimmer Biomet in Q4 2016 and held it in 6 quarters.
  • Empire Life Investments's Zimmer Biomet position peaked at $52.9M in Q2 2017.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Empire Life Investments's 13F filing for Q2 2018, filed 14 Aug 2018.